Cargando…

Association of Angiotensin II–Stimulating Antihypertensive Use and Dementia Risk: Post Hoc Analysis of the PreDIVA Trial

OBJECTIVE: To assess whether angiotensin II–stimulating antihypertensives (thiazides, dihydropyridine calcium channel blockers, and angiotensin I receptor blockers) convey a lower risk of incident dementia compared to angiotensin II–inhibiting antihypertensives (angiotensin-converting enzyme inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dalen, Jan Willem, Marcum, Zachary A., Gray, Shelly L., Barthold, Douglas, Moll van Charante, Eric P., van Gool, Willem A., Crane, Paul K., Larson, Eric B., Richard, Edo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884979/ https://www.ncbi.nlm.nih.gov/pubmed/33154085 http://dx.doi.org/10.1212/WNL.0000000000010996

Ejemplares similares

Modifiable dementia risk score to study heterogeneity in treatment effect of a dementia prevention trial: a post hoc analysis in the preDIVA trial using the LIBRA index
por: van Middelaar, Tessa, et al.
Publicado: (2018)

Do Patient Concerns About Antihypertensive Use For Dementia Prevention Vary By Current Use Of Antihypertensive?
por: Lee, Woojung, et al.
Publicado: (2019)

Antihypertensive medication classes and the risk of dementia over a decade of follow-up
por: Schroevers, Jakob L., et al.
Publicado: (2023)

Sex Differences in the Relation Between Subjective Memory Complaints, Impairments in Instrumental Activities of Daily Living, and Risk of Dementia
por: Abdulrahman, Herrer, et al.
Publicado: (2022)

Longitudinal relation between blood pressure, antihypertensive use and cerebral blood flow, using arterial spin labelling MRI
por: van Dalen, Jan Willem, et al.
Publicado: (2020)

Apathy is associated with incident dementia in community-dwelling older people
por: van Dalen, Jan Willem, et al.
Publicado: (2018)

Year-by-Year Blood Pressure Variability From Midlife to Death and Lifetime Dementia Risk
por: den Brok, Melina G. H. E., et al.
Publicado: (2023)

A Population Perspective on Prevention of Dementia
por: Eggink, Esmé, et al.
Publicado: (2019)

Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review
por: Ligthart, Suzanne A, et al.
Publicado: (2010)

Low Values for Blood Pressure, BMI, and Non-HDL Cholesterol and the Risk of Late-Life Dementia
por: den Brok, Melina G.H.E., et al.
Publicado: (2022)

Patterns of antihypertensive and statin adherence prior to dementia: findings from the adult changes in thought study
por: Marcum, Zachary A., et al.
Publicado: (2019)

Beliefs about benefits and harms of medications and supplements for brain health
por: Marcum, Zachary A., et al.
Publicado: (2020)

A cardiovascular risk prediction model for older people: Development and validation in a primary care population
por: van Bussel, Emma F., et al.
Publicado: (2019)

Prescribing and deprescribing antihypertensive medication in older people by Dutch general practitioners: a qualitative study
por: van Middelaar, Tessa, et al.
Publicado: (2018)

Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of Meynert
por: van Dalen, Jan Willem, et al.
Publicado: (2016)

Diva
por: Matheopoulos, Helena
Publicado: (1993)

Web-Based Interventions Targeting Cardiovascular Risk Factors in Middle-Aged and Older People: A Systematic Review and Meta-Analysis
por: Beishuizen, Cathrien RL, et al.
Publicado: (2016)

Las divas
por: Torres, Juan Manuel
Publicado: (1962)

Factors Predicting Engagement of Older Adults With a Coach-Supported eHealth Intervention Promoting Lifestyle Change and Associations Between Engagement and Changes in Cardiovascular and Dementia Risk: Secondary Analysis of an 18-Month Multinational Randomized Controlled Trial
por: Coley, Nicola, et al.
Publicado: (2022)

Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries
por: Marcum, Zachary A., et al.
Publicado: (2023)

Hypertension and Alzheimer's disease pathology at autopsy: A systematic review
por: Abdulrahman, Herrer, et al.
Publicado: (2022)

Hypertension management: experiences, wishes and concerns among older people—a qualitative study
por: van Bussel, Emma, et al.
Publicado: (2019)

Attitudes and views on healthy lifestyle interventions for the prevention of dementia and cardiovascular disease among older people with low socioeconomic status: a qualitative study in the Netherlands
por: Eggink, Esmé, et al.
Publicado: (2022)

MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study
por: Richard, Edo, et al.
Publicado: (2013)

Engaging older people in an internet platform for cardiovascular risk self-management: a qualitative study among Dutch HATICE participants
por: van Middelaar, Tessa, et al.
Publicado: (2018)

Bayes analysis supports null hypothesis of anti‐amyloid beta therapy in Alzheimer's disease
por: Richard, Edo, et al.
Publicado: (2021)

Perspectives of older people engaging in nurse-led cardiovascular prevention programmes: a qualitative study in primary care in the Netherlands
por: Ligthart, Suzanne A, et al.
Publicado: (2015)

Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment
por: Marcum, Zachary A., et al.
Publicado: (2022)

Exchange of C-Terminal Variable Sequences within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) against PPR
por: Selvaraj, Muneeswaran, et al.
Publicado: (2021)

Telephone and Smartphone-Based Interventions for Cognitive and Cardio-Metabolic Health in Middle-Aged and Older Adults: A Systematic Review
por: Andre, Laurine, et al.
Publicado: (2022)

New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT
por: King, Jordan B., et al.
Publicado: (2023)

Can We Prevent, Delay, or Shorten the Course of Dementia?
por: Van Gool, Willem A
Publicado: (2006)

Assessing the Effectiveness of mHealth Interventions for Diabetes and Hypertension Management in Africa: Systematic Review and Meta-Analysis
por: Aovare, Pearl, et al.
Publicado: (2023)

Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment
por: Richard, Edo, et al.
Publicado: (2016)

Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
por: Jelsma, Tinka, et al.
Publicado: (2021)

Aujeszky’s Disease and the Development of the Marker/DIVA Vaccination Concept
por: Mettenleiter, Thomas C.
Publicado: (2020)

Dementia incidence trend over 1992-2014 in the Netherlands: Analysis of primary care data
por: van Bussel, Emma F., et al.
Publicado: (2017)

Atherosclerotic risk is associated with cerebral perfusion – A cross-sectional study using arterial spin labeling MRI
por: Hafdi, Melanie, et al.
Publicado: (2022)

Use of ethnic identifiers to narrow health inequality gaps
por: van Apeldoorn, Joshua A.N., et al.
Publicado: (2022)

DIVA metabolomics: Differentiating vaccination status following viral challenge using metabolomic profiles
por: Gray, Darren W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_si9pp41vj4ivgsjljejpe14pme